InvestorsHub Logo
Followers 110
Posts 20257
Boards Moderated 0
Alias Born 05/08/2008

Re: DL11 post# 192948

Thursday, 03/21/2019 8:11:07 AM

Thursday, March 21, 2019 8:11:07 AM

Post# of 211607
Your Question 1: "How much in sales/revenue growth needed to sustain share price of $10 by end of year?"

At current OS plus 2M for investor Warrants and Pref Es which are now all issued (future known dilution), we can start with a round 8M shares to calculate the the annual sales. For a company growing at a rate of 30%/yr (an optimistic value at this time, since sales are declining), a market cap to sales ratio of 5X, I'm assuming. $10 PPS X 8M = $80M mkt cap. $80M / 5 multiplier = $16M in sales revenue. Given that sales aren't growing yet, the 5 multiplier would actually be 1X or even less. Plus nothing has been added for conversions of Rich's Pref C/Ds (will at least double OS overnight), nor for shares issued to buy Green Grow (totally unknown at this time). All these things considered, sales might have to be $800M to $1B to hit $10 PPS by end of this year.

Your Question 2: "All the news is great! How much time does the company have to grow sales and revenue from their various intiatives?"

Much of the news is great and much of that hasn't yet occurred. The four sources of extra dilution are not great, especially 2 of them since they add no shareholder value, only enrich Rich. As far as how much time do they have ...years I guess. He's spent 14 so far since inception of Iconic in 2005 and has only $20M in cumulative losses (according to his audited fins) to show for it. Hempology will be his 10th product. It's a growing market, so it could pan out for him. Until he stops the excessive dilution, I'm not seeing it panning out for shareholders. But he might cancel the Pref C/Ds an not issue shares if he changes his mind from what was in PR earlier this week.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ICNB News